Ii-Key/HER2/neu cancer vaccine: Completed Phase II enrollment

Generex completed enrollment of >300 patients with node-positive or high-risk, node-negative breast cancer in a single-blind, international Phase II trial evaluating 6 monthly intradermal inoculations...